Molecular Endocrinology, Vol 10, 24-34, Copyright © 1996 by Endocrine Society

ARTICLES

Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination

S Zhang, X Liang and M Danielsen
Department of Biochemistry and Molecular Biology, Georgetown University Medical School, Washington, DC 20007, USA.

The glucocorticoid receptor (GR) is a hormone-inducible intracellular modulator of specific gene transcription. Both glucocorticoids and progestins bind to the GR, and some progestins are able to activate the receptor. We have characterized a mutation of the mouse GR that restricts transcriptional activation, but not hormone binding, to glucocorticoids. This mutation, Y77ON, is located 13 amino acids from the C terminus of the mouse GR and helps define a region of the receptor that is important for transcriptional specificity. To further characterize this region of the GR, we have constructed a series of chimeric receptors between the glucocorticoid, progesterone, and androgen receptors. We find that the C-terminal 14 amino acids of the GR can be replaced by the equivalent region of the progesterone or androgen receptors with little alteration in either hormone-binding specificity or transcriptional response to agonists and antagonists. The region is required for hormone binding, however, since C-terminal deletions yield inactive receptors. We conclude that even though mutation of the C-terminal 14 amino acids of the GR can lead to alterations in hormone binding specificity and agonist potential, the differential hormone-binding capacities of the glucocorticoid, progesterone, and androgen receptors are not encoded in this region.

This article has been cited by other articles:

				E. Charmandari, T. Kino, T. Ichijo, and G. P. Chrousos Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic Disorder J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1563 - 1572. [Abstract] [Full Text] [PDF]

				F. G. Riepe, J. Finkeldei, L. de Sanctis, S. Einaudi, A. Testa, B. Karges, M. Peter, M. Viemann, J. Grotzinger, W. G. Sippell, et al. Elucidating the Underlying Molecular Pathogenesis of NR3C2 Mutants Causing Autosomal Dominant Pseudohypoaldosteronism Type 1 J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4552 - 4561. [Abstract] [Full Text] [PDF]

				P. Servert, J. Garcia-Castro, V. Diaz, D. Lucas, M. A. Gonzalez, C. Martinez-A, and A. Bernad Inducible model for {beta}-six-mediated site-specific recombination in mammalian cells Nucleic Acids Res., January 3, 2006; 34(1): e1 - e1. [Abstract] [Full Text] [PDF]

				P. Carlsson, K. F. Koehler, and L. Nilsson Glucocorticoid Receptor Point Mutation V571M Facilitates Coactivator and Ligand Binding by Structural Rearrangement and Stabilization Mol. Endocrinol., August 1, 2005; 19(8): 1960 - 1977. [Abstract] [Full Text] [PDF]

				E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, K. Zachman, and G. P. Chrousos A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3696 - 3705. [Abstract] [Full Text] [PDF]

				B. Farboud and M. L. Privalsky Retinoic Acid Receptor-{alpha} Is Stabilized in a Repressive State by Its C-Terminal, Isotype-Specific F Domain Mol. Endocrinol., December 1, 2004; 18(12): 2839 - 2853. [Abstract] [Full Text] [PDF]

				M. R. Yudt, C. M. Jewell, R. J. Bienstock, and J. A. Cidlowski Molecular Origins for the Dominant Negative Function of Human Glucocorticoid Receptor Beta Mol. Cell. Biol., June 15, 2003; 23(12): 4319 - 4330. [Abstract] [Full Text] [PDF]

				M. A. Loven, N. Muster, J. R. Yates, and A. M. Nardulli A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation Mol. Endocrinol., January 1, 2003; 17(1): 67 - 78. [Abstract] [Full Text] [PDF]

				Y. He, D. Szapary, and S. S. Simons Jr. Modulation of Induction Properties of Glucocorticoid Receptor-Agonist and -Antagonist Complexes by Coactivators Involves Binding to Receptors but Is Independent of Ability of Coactivators to Augment Transactivation J. Biol. Chem., December 13, 2002; 277(51): 49256 - 49266. [Abstract] [Full Text] [PDF]

				R. Dey, P. Roychowdhury, and C. Mukherjee Homology modelling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone Protein Eng. Des. Sel., August 1, 2001; 14(8): 565 - 571. [Abstract] [Full Text] [PDF]

				F. M. Sladek, M. D. Ruse Jr., L. Nepomuceno, S.-M. Huang, and M. R. Stallcup Modulation of Transcriptional Activation and Coactivator Interaction by a Splicing Variation in the F Domain of Nuclear Receptor Hepatocyte Nuclear Factor 4alpha 1 Mol. Cell. Biol., October 1, 1999; 19(10): 6509 - 6522. [Abstract] [Full Text] [PDF]

				U. Lind, P. Greenidge, J.-A. Gustafsson, A. P. H. Wright, and J. Carlstedt-Duke Valine 571 Functions as a Regional Organizer in Programming the Glucocorticoid Receptor for Differential Binding of Glucocorticoids and Mineralocorticoids J. Biol. Chem., June 25, 1999; 274(26): 18515 - 18523. [Abstract] [Full Text] [PDF]

				J. G. A. Savory, B. Hsu, I. R. Laquian, W. Giffin, T. Reich, R. J. G. Hache, and Y. A. Lefebvre Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor Mol. Cell. Biol., February 1, 1999; 19(2): 1025 - 1037. [Abstract] [Full Text] [PDF]

				J. Lu and M. Danielsen Differential Regulation of Androgen and Glucocorticoid Receptors by Retinoblastoma Protein J. Biol. Chem., November 20, 1998; 273(47): 31528 - 31533. [Abstract] [Full Text] [PDF]

				B. Couette, S. Jalaguier, C. Hellal-Levy, B. Lupo, J. Fagart, G. Auzou, and M.-E. Rafestin-Oblin Folding Requirements of the Ligand-Binding Domain of the Human Mineralocorticoid Receptor Mol. Endocrinol., June 1, 1998; 12(6): 855 - 863. [Abstract] [Full Text]

				K. J. Modarress, J. Opoku, M. Xu, N. J. Sarlis, and S. S. Simons Jr. Steroid-induced Conformational Changes at Ends of the Hormone-binding Domain in the Rat Glucocorticoid Receptor Are Independent of Agonist Versus Antagonist Activity J. Biol. Chem., September 19, 1997; 272(38): 23986 - 23994. [Abstract] [Full Text] [PDF]

				M. Xu, P. K. Chakraborti, M. J. Garabedian, K. R. Yamamoto, and S. S. Simons Jr. Modular Structure of Glucocorticoid Receptor Domains Is Not Equivalent to Functional Independence. STABILITY AND ACTIVITY OF THE STEROID BINDING DOMAIN ARE CONTROLLED BY SEQUENCES IN SEPARATE DOMAINS J. Biol. Chem., August 30, 1996; 271(35): 21430 - 21438. [Abstract] [Full Text] [PDF]